Sanofi-Aventis U.S. Award

sanofi-aventis U.S. Award
ASM's premier award in antimicrobial chemotherapy research; it stimulates research and honors outstanding accomplishment in antimicrobial chemotherapy. Nominees must be actively engaged in research involving development of new agents, investigation of antimicrobial action or resistance to antimicrobial agents, and/or the pharmacology, toxicology or clinical use of those agents. Nominees must not have served on the ICAAC Program Committee within the past two years.

Award: A cash prize of $20,000, a commemorative medal, and travel to ICAAC where the laureate delivers the sanofi-aventis U.S. Award Lecture. ASM awards are granted at the discretion of award selection committees and may not be awarded every year.

Deadline: April 1.

Nominations: Nominations will be considered without updating for three years; self-nominations will not be accepted. Nominations must consist of the following:

*Curriculum vitae, including a list of publications.

*Letter of nomination. Describe the nominee's outstanding accomplishment in antimicrobial chemotherapy, including a list of the ten most relevant publications to the award.

*Letters of support. Two letters of support should come from two people, other than the nominator, who are familiar with the nominee's accomplishments.

No more than one of the three letters may be from the nominee's institution or the same institution.
Email all nomination components to awards@asmusa.org.